Inducible IL-33 expression by mast cells is regulated by a calcium-dependent pathway

Journal of Immunology

Volumn 189, Issue 7, 2012, Pages 3421-3429

  Hsu, Chia Lin ^a   Bryce, Paul J ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; IMMUNOGLOBULIN E; IMMUNOGLOBULIN E RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 33; MESSENGER RNA; PHOSPHATIDYLINOSITOL 3 KINASE; SHORT HAIRPIN RNA; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE KINASE 1; SPHINGOSINE KINASE 2; TRANSCRIPTION FACTOR NFAT;

ANIMAL CELL; ARTICLE; AUTOCRINE EFFECT; BINDING SITE; CALCIUM MOBILIZATION; CELL ACTIVATION; CONTROLLED STUDY; EPITHELIUM CELL; EXON; FIBROBLAST; GENE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; INTERLEUKIN 33 GENE; MAST CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CROSS LINKING; TRANSCRIPTION INITIATION SITE; UPREGULATION;

ANIMALS; BINDING SITES; BONE MARROW CELLS; CALCIUM; CALCIUM SIGNALING; CELL LINE; CROSS-LINKING REAGENTS; HUMANS; IMMUNOGLOBULIN E; INTERLEUKINS; MAST CELLS; MICE; MICE, INBRED C57BL; NF-KAPPA B; NFATC TRANSCRIPTION FACTORS; NIH 3T3 CELLS; RECEPTORS, IGE; RNA, MESSENGER; TRANSCRIPTIONAL ACTIVATION;

EID: 84866551191     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1201224     Document Type: Article

References (60)

1. Schmitz, J., A. Owyang, E. Oldham, Y. Song, E. Murphy, T. K. McClanahan, G. Zurawski, M. Moshrefi, J. Qin, X. Li, et al. 2005. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 23: 479-490. (Pubitemid 41587888)
2. Baekkevold, E. S., M. Roussigné, T. Yamanaka, F. E. Johansen, F. L. Jahnsen, F. Amalric, P. Brandtzaeg, M. Erard, G. Haraldsen, and J. P. Girard. 2003. Molecular characterization of NF-HEV, a nuclear factor preferentially expressed in human high endothelial venules. Am. J. Pathol. 163: 69-79. (Pubitemid 36759592)
3. Carriere, V., L. Roussel, N. Ortega, D. A. Lacorre, L. Americh, L. Aguilar, G. Bouche, and J. P. Girard. 2007. IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo. Proc. Natl. Acad. Sci. USA 104: 282-287. (Pubitemid 46068023)
4. Chackerian, A. A., E. R. Oldham, E. E. Murphy, J. Schmitz, S. Pflanz, and R. A. Kastelein. 2007. IL-1 receptor accessory protein and ST2 comprise the IL-33 receptor complex. J. Immunol. 179: 2551-2555.
5. Ali, S., M. Huber, C. Kollewe, S. C. Bischoff, W. Falk, and M. U. Martin. 2007. IL-1 receptor accessory protein is essential for IL-33-induced activation of T lymphocytes and mast cells. Proc. Natl. Acad. Sci. USA 104: 18660-18665. (Pubitemid 350210753)
6. Pecaric-Petkovic, T., S. A. Didichenko, S. Kaempfer, N. Spiegl, and C. A. Dahinden. 2009. Human basophils and eosinophils are the direct target leukocytes of the novel IL-1 family member IL-33. Blood 113: 1526-1534.
7. Smithgall, M. D., M. R. Comeau, B. R. Yoon, D. Kaufman, R. Armitage, and D. E. Smith. 2008. IL-33 amplifies both Th1- and Th2-type responses through its activity on human basophils, allergen-reactive Th2 cells, iNKT and NK cells. Int. Immunol. 20: 1019-1030.
8. Iikura, M., H. Suto, N. Kajiwara, K. Oboki, T. Ohno, Y. Okayama, H. Saito, S. J. Galli, and S. Nakae. 2007. IL-33 can promote survival, adhesion and cytokine production in human mast cells. Lab. Invest. 87: 971-978. (Pubitemid 47429189)
9. Moulin, D., O. Donzé, D. Talabot-Ayer, F. Mézin, G. Palmer, and C. Gabay. 2007. Interleukin (IL)-33 induces the release of pro-inflammatory mediators by mast cells. Cytokine 40: 216-225. (Pubitemid 350213434)
10. Komai-Koma, M., D. Xu, Y. Li, A. N. McKenzie, I. B. McInnes, and F. Y. Liew. 2007. IL-33 is a chemoattractant for human Th2 cells. Eur. J. Immunol. 37: 2779-2786. (Pubitemid 47578297)
11. Kondo, Y., T. Yoshimoto, K. Yasuda, S. Futatsugi-Yumikura, M. Morimoto, N. Hayashi, T. Hoshino, J. Fujimoto, and K. Nakanishi. 2008. Administration of IL-33 induces airway hyperresponsiveness and goblet cell hyperplasia in the lungs in the absence of adaptive immune system. Int. Immunol. 20: 791-800. (Pubitemid 351791523)
12. Kurowska-Stolarska, M., P. Kewin, G. Murphy, R. C. Russo, B. Stolarski, C. C. Garcia, M. Komai-Koma, N. Pitman, Y. Li, W. Niedbala, et al. 2008. IL-33 induces antigen-specific IL-5+ T cells and promotes allergic-induced airway inflammation independent of IL-4. J. Immunol. 181: 4780-4790.
13. Oboki, K., T. Ohno, N. Kajiwara, H. Saito, and S. Nakae. 2010. IL-33 and IL-33 receptors in host defense and diseases. Allergol. Int. 59: 143-160.
14. Humphreys, N. E., D. Xu, M. R. Hepworth, F. Y. Liew, and R. K. Grencis. 2008. IL-33, a potent inducer of adaptive immunity to intestinal nematodes. J. Immunol. 180: 2443-2449.
15. Matsuba-Kitamura, S., T. Yoshimoto, K. Yasuda, S. Futatsugi-Yumikura, Y. Taki, T. Muto, T. Ikeda, O. Mimura, and K. Nakanishi. 2010. Contribution of IL-33 to induction and augmentation of experimental allergic conjunctivitis. Int. Immunol. 22: 479-489.
16. Pushparaj, P. N., H. K. Tay, S. C. H'ng, N. Pitman, D. Xu, A. McKenzie, F. Y. Liew, and A. J. Melendez. 2009. The cytokine interleukin-33 mediates anaphylactic shock. Proc. Natl. Acad. Sci. USA 106: 9773-9778.
17. Küchler, A. M., J. Pollheimer, J. Balogh, J. Sponheim, L. Manley, D. R. Sorensen, P. M. De Angelis, H. Scott, and G. Haraldsen. 2008. Nuclear interleukin-33 is generally expressed in resting endothelium but rapidly lost upon angiogenic or proinflammatory activation. Am. J. Pathol. 173: 1229-1242.
18. Sponheim, J., J. Pollheimer, T. Olsen, J. Balogh, C. Hammarström, T. Loos, M. Kasprzycka, D. R. Sørensen, H. R. Nilsen, A. M. Küchler, et al. 2010. Inflammatory bowel disease-associated interleukin-33 is preferentially expressed in ulceration-associated myofibroblasts. Am. J. Pathol. 177: 2804-2815.
19. Moussion, C., N. Ortega, and J. P. Girard. 2008. The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel "alarmin"? PLoS ONE 3: e3331.
20. Masamune, A., T. Watanabe, K. Kikuta, K. Satoh, A. Kanno, and T. Shimosegawa. 2010. Nuclear expression of interleukin-33 in pancreatic stellate cells. Am. J. Physiol. Gastrointest. Liver Physiol. 299: G821-G832.
21. Zhang, L., R. Lu, G. Zhao, S. C. Pflugfelder, and D. Q. Li. 2011. TLR-mediated induction of pro-allergic cytokine IL-33 in ocular mucosal epithelium. Int. J. Biochem. Cell Biol. 43: 1383-1391.
22. 2 enhances IL-33 production by dendritic cells. Immunol. Lett. 141: 55-60.
23. Nile, C. J., E. Barksby, P. Jitprasertwong, P. M. Preshaw, and J. J. Taylor. 2010. Expression and regulation of interleukin-33 in human monocytes. Immunology 130: 172-180.
24. Talabot-Ayer, D., C. Lamacchia, C. Gabay, and G. Palmer. 2009. Interleukin-33 is biologically active independently of caspase-1 cleavage. J. Biol. Chem. 284: 19420-19426.
25. Ohno, T., K. Oboki, N. Kajiwara, E. Morii, K. Aozasa, R. A. Flavell, K. Okumura, H. Saito, and S. Nakae. 2009. Caspase-1, caspase-8, and calpain are dispensable for IL-33 release by macrophages. J. Immunol. 183: 7890-7897.
26. H2 pathway. Nature 475: 110-113.
27. Hsu, C. L., C. V. Neilsen, and P. J. Bryce. 2010. IL-33 is produced by mast cells and regulates IgE-dependent inflammation. PLoS ONE 5: e11944.
28. Allakhverdi, Z., D. E. Smith, M. R. Comeau, and G. Delespesse. 2007. Cutting edge: the ST2 ligand IL-33 potently activates and drives maturation of human mast cells. J. Immunol. 179: 2051-2054.
29. Ho, L. H., T. Ohno, K. Oboki, N. Kajiwara, H. Suto, M. Iikura, Y. Okayama, S. Akira, H. Saito, S. J. Galli, and S. Nakae. 2007. IL-33 induces IL-13 production by mouse mast cells independently of IgE-FcεRI signals. J. Leukoc. Biol. 82: 1481-1490. (Pubitemid 350276960)
30. Gilfillan, A. M., and J. Rivera. 2009. The tyrosine kinase network regulating mast cell activation. Immunol. Rev. 228: 149-169.
31. Olivera, A. 2008. Unraveling the complexities of sphingosine-1-phosphate function: the mast cell model. Prostaglandins Other Lipid Mediat. 86: 1-11.
32. Olivera, A., N. Urtz, K. Mizugishi, Y. Yamashita, A. M. Gilfillan, Y. Furumoto, H. Gu, R. L. Proia, T. Baumruker, and J. Rivera. 2006. IgE-dependent activation of sphingosine kinases 1 and 2 and secretion of sphingosine 1-phosphate requires Fyn kinase and contributes to mast cell responses. J. Biol. Chem. 281: 2515-2525. (Pubitemid 43845711)
33. Pfaffl, M. W. 2001. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29: e45.
34. Neal, J. W., and N. A. Clipstone. 2003. A constitutively active NFATc1 mutant induces a transformed phenotype in 3T3-L1 fibroblasts. J. Biol. Chem. 278: 17246-17254. (Pubitemid 36799606)
35. Rivera, J., and A. Olivera. 2008. A current understanding of FcεRI-dependent mast cell activation. Curr. Allergy Asthma Rep. 8: 14-20. (Pubitemid 351459688)
36. Edsall, L. C., J. R. Van Brocklyn, O. Cuvillier, B. Kleuser, and S. Spiegel. 1998. N,N-Dimethylsphingosine is a potent competitive inhibitor of sphingosine kinase but not of protein kinase C: modulation of cellular levels of sphingosine 1-phosphate and ceramide. Biochemistry 37: 12892-12898. (Pubitemid 28433522)
37. Michaud, J., M. Kohno, R. L. Proia, and T. Hla. 2006. Normal acute and chronic inflammatory responses in sphingosine kinase 1 knockout mice. FEBS Lett. 580: 4607-4612. (Pubitemid 44189376)
38. Igarashi, Y., S. Hakomori, T. Toyokuni, B. Dean, S. Fujita, M. Sugimoto, T. Ogawa, K. el-Ghendy, and E. Racker. 1989. Effect of chemically well-defined sphingosine and its N-methyl derivatives on protein kinase C and src kinase activities. Biochemistry 28: 6796-6800. (Pubitemid 19219864)
39. Rivera, J., R. L. Proia, and A. Olivera. 2008. The alliance of sphingosine-1-phosphate and its receptors in immunity. Nat. Rev. Immunol. 8: 753-763.
40. Oskeritzian, C. A., M. M. Price, N. C. Hait, D. Kapitonov, Y. T. Falanga, J. K. Morales, J. J. Ryan, S. Milstien, and S. Spiegel. 2010. Essential roles of sphingosine-1-phosphate receptor 2 in human mast cell activation, anaphylaxis, and pulmonary edema. J. Exp. Med. 207: 465-474.
41. Pushparaj, P. N., J. Manikandan, H. K. Tay, S. C. H'ng, S. D. Kumar, J. Pfeilschifter, A. Huwiler, and A. J. Melendez. 2009. Sphingosine kinase 1 is pivotal for FcεRI-mediated mast cell signaling and functional responses in vitro and in vivo. J. Immunol. 183: 221-227.
42. Dolmetsch, R. E., K. Xu, and R. S. Lewis. 1998. Calcium oscillations increase the efficiency and specificity of gene expression. Nature 392: 933-936. (Pubitemid 28232066)
43. Ferrero-Miliani, L., O. H. Nielsen, P. S. Andersen, and S. E. Girardin. 2007. Chronic inflammation: importance of NOD2 and NALP3 in interleukin-1β generation. Clin. Exp. Immunol. 147: 227-235. (Pubitemid 46095999)
44. Talabot-Ayer, D., N. Calo, S. Vigne, C. Lamacchia, C. Gabay, and G. Palmer. 2012. The mouse interleukin (Il)33 gene is expressed in a cell type- and stimulus-dependent manner from two alternative promoters. J. Leukoc. Biol. 91: 119-125.
45. Feo, S., V. Antona, G. Barbieri, R. Passantino, L. Calì, and A. Giallongo. 1995. Transcription of the human b enolase gene (ENO-3) is regulated by an intronic muscle-specific enhancer that binds myocyte-specific enhancer factor 2 proteins and ubiquitous G-rich-box binding factors. Mol. Cell. Biol. 15: 5991-6002.
46. Dutton, J. R., A. Antonellis, T. J. Carney, F. S. Rodrigues, W. J. Pavan, A. Ward, and R. N. Kelsh. 2008. An evolutionarily conserved intronic region controls the spatiotemporal expression of the transcription factor Sox10. BMC Dev. Biol. 8: 105.
47. Lee, J. H., L. C. Wang, H. H. Yu, Y. T. Lin, Y. H. Yang, and B. L. Chiang. 2010. Type I IL-1 receptor (IL-1RI) as potential new therapeutic target for bronchial asthma. Mediators Inflamm. 2010: 567351.
48. Saidi, S., F. Bouri, P. Lencel, L. Duplomb, M. Baud'huin, S. Delplace, D. Leterme, F. Miellot, D. Heymann, P. Hardouin, et al. 2011. IL-33 is expressed in human osteoblasts, but has no direct effect on bone remodeling. Cytokine 53: 347-354.
49. Keller, M., A. Rüegg, S. Werner, and H. D. Beer. 2008. Active caspase-1 is a regulator of unconventional protein secretion. Cell 132: 818-831. (Pubitemid 351312798)
50. Andrade, M. V., S. Iwaki, C. Ropert, R. T. Gazzinelli, J. R. Cunha-Melo, and M. A. Beaven. 2011. Amplification of cytokine production through synergistic activation of NFAT and AP-1 following stimulation of mast cells with antigen and IL-33. Eur. J. Immunol. 41: 760-772.
51. 2+ signaling in mast cells. Immunol. Rev. 231: 45-58.
52. Vig, M., W. I. DeHaven, G. S. Bird, J. M. Billingsley, H. Wang, P. E. Rao, A. B. Hutchings, M. H. Jouvin, J. W. Putney, and J. P. Kinet. 2008. Defective mast cell effector functions in mice lacking the CRACM1 pore subunit of store-operated calcium release-activated calcium channels. Nat. Immunol. 9: 89-96. (Pubitemid 350286208)
53. Baba, Y., K. Nishida, Y. Fujii, T. Hirano, M. Hikida, and T. Kurosaki. 2008. Essential function for the calcium sensor STIM1 in mast cell activation and anaphylactic responses. Nat. Immunol. 9: 81-88. (Pubitemid 350286207)
54. 2+ channels by 2-aminoethyldiphenyl borate (2-APB) occurs independently of IP3 receptors. J. Physiol. 536: 3-19.
55. Broad, L. M., F. J. Braun, J. P. Lievremont, G. S. Bird, T. Kurosaki, and J. W. Putney, Jr. 2001. Role of the phospholipase C-inositol 1,4,5-trisphosphate pathway in calcium release-activated calcium current and capacitative calcium entry. J. Biol. Chem. 276: 15945-15952.
56. Olivera, A., C. Eisner, Y. Kitamura, S. Dillahunt, L. Allende, G. Tuymetova, W. Watford, F. Meylan, S. C. Diesner, L. Li, et al. 2010. Sphingosine kinase 1 and sphingosine-1-phosphate receptor 2 are vital to recovery from anaphylactic shock in mice. J. Clin. Invest. 120: 1429-1440.
57. Olivera, A., K. Mizugishi, A. Tikhonova, L. Ciaccia, S. Odom, R. L. Proia, and J. Rivera. 2007. The sphingosine kinase-sphingosine-1-phosphate axis is a determinant of mast cell function and anaphylaxis. Immunity 26: 287-297. (Pubitemid 46413904)
58. Hogan, P. G., L. Chen, J. Nardone, and A. Rao. 2003. Transcriptional regulation by calcium, calcineurin, and NFAT. Genes Dev. 17: 2205-2232. (Pubitemid 37128637)
59. Monticelli, S., D. C. Solymar, and A. Rao. 2004. Role of NFAT proteins in IL13 gene transcription in mast cells. J. Biol. Chem. 279: 36210-36218. (Pubitemid 39128956)
60. Klein, M., S. Klein-Hessling, A. Palmetshofer, E. Serfling, C. Tertilt, T. Bopp, V. Heib, M. Becker, C. Taube, H. Schild, et al. 2006. Specific and redundant roles for NFAT transcription factors in the expression of mast cell-derived cytokines. J. Immunol. 177: 6667-6674. (Pubitemid 44715030)